PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis

被引:153
作者
Lee, Min-Sik [1 ]
Jeong, Man-Hyung [1 ]
Lee, Hyun-Woo [2 ]
Han, Hyun-Ji [1 ]
Ko, Aram [1 ]
Hewitt, Stephen M. [3 ]
Kim, Jae-Hoon [4 ,5 ]
Chun, Kyung-Hee [2 ]
Chung, Joon-Yong [3 ]
Lee, Cheolju [6 ]
Cho, Hanbyoul [4 ,5 ]
Song, Jaewhan [1 ]
机构
[1] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea
[3] NCI, Expt Pathol Lab, Ctr Canc Res, NIH MSC 1500, Bethesda, MD 20892 USA
[4] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Obstet & Gynecol, Seoul 135720, South Korea
[5] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul 120752, South Korea
[6] Korea Inst Sci & Technol, BRI, Seoul 136791, South Korea
来源
NATURE COMMUNICATIONS | 2015年 / 6卷
基金
新加坡国家研究基金会;
关键词
POSTTRANSLATIONAL REGULATION; GERMLINE MUTATIONS; TUMOR SUPPRESSION; CANCER; GENE; DEGRADATION; APOPTOSIS; PATHWAY; LIGASE; CELLS;
D O I
10.1038/ncomms8769
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The activity of the phosphatase and tensin homologue (PTEN) is known to be suppressed via post-translational modification. However, the mechanism and physiological significance by which post-translational modifications lead to PTEN suppression remain unclear. Here we demonstrate that PTEN destabilization is induced by EGFR-or oncogenic PI3K mutation-mediated AKT activation in cervical cancer. EGFR/PI3K/AKT-mediated ubiquitination and degradation of PTEN are dependent on the MKRN1 E3 ligase. These processes require the stabilization of MKRN1 via AKT-mediated phosphorylation. In cervical cancer patients with high levels of pAKT and MKRN1 expression, PTEN protein levels are low and correlate with a low 5-year survival rate. Taken together, our results demonstrate that PI3K/AKT signals enforce positive-feedback regulation by suppressing PTEN function.
引用
收藏
页数:14
相关论文
共 41 条
[1]   The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation [J].
Ahmed, Syed Feroj ;
Deb, Satamita ;
Paul, Indranil ;
Chatterjee, Anirban ;
Mandal, Tapashi ;
Chatterjee, Uttara ;
Ghosh, Mrinal K. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (19) :15996-16006
[2]   Immunogenicity of constitutively active V599EBRaf [J].
Andersen, MH ;
Fensterle, J ;
Ugurel, S ;
Reker, S ;
Houben, R ;
Guldberg, P ;
Berger, TG ;
Schadendorf, D ;
Trefzer, U ;
Bröcker, EB ;
Straten, PT ;
Rapp, UR ;
Becker, JC .
CANCER RESEARCH, 2004, 64 (15) :5456-5460
[3]   PTEN hamartoma tumor syndromes [J].
Blumenthal, Gideon M. ;
Dennis, Phillip A. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (11) :1289-1300
[4]   Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer [J].
Burri, N ;
Shaw, P ;
Bouzourene, H ;
Sordat, I ;
Sordat, B ;
Gillet, M ;
Schorderet, D ;
Bosman, FT ;
Chaubert, P .
LABORATORY INVESTIGATION, 2001, 81 (02) :217-229
[5]   Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6 [J].
Camus, S ;
Higgins, M ;
Lane, DP ;
Lain, S .
FEBS LETTERS, 2003, 536 (1-3) :220-224
[6]   PTEN and the PI3-Kinase Pathway in Cancer [J].
Chalhoub, Nader ;
Baker, Suzanne J. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :127-150
[7]  
CHEN TM, 1993, CANCER RES, V53, P1167
[8]   The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma [J].
Chung, Joon-Yong ;
Hong, Seung-Mo ;
Choi, Byeong Yeob ;
Cho, HyungJun ;
Yu, Eunsil ;
Hewitt, Stephen M. .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :660-667
[9]   Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis [J].
Cully, M ;
You, H ;
Levine, AJ ;
Mak, TW .
NATURE REVIEWS CANCER, 2006, 6 (03) :184-192
[10]   Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study [J].
Dalstein, W ;
Riethmuller, D ;
Prétet, JL ;
Carval, KL ;
Sautière, JL ;
Carbillet, JP ;
Kantelip, B ;
Schaal, JP ;
Mougin, C .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :396-403